Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2023 Earnings Conference Call October 24, 2023 9:00 AM ET Company Participants Lauren Morris - Director, IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO David Windley - Jefferies John Sourbeer - UBS Eric Coldwell - Baird Jack Wallace - Guggenheim Partners Christine Rains - William Blair Operator Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call ma ...

1.38x 1.49x 17.7% 17.6% 1.28x 1.28x 1.23x 1.23x 1.28x 1.25x 17.0% 16.7% 16.6% 16.8% 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 Net New Business Awards ($ in millions) MAKING THE COMPLEX SEAMLESS Q2 2023 – KEY FINANCIAL HIGHLIGHTS A. See the appendix for the non-GAAP reconciliation of the EBITDA calculations. B. Net income per diluted share for 2Q23 and 2Q22 excludes $0.041 million and $0.031 million, respectively, in undistributed earnings allocated to RSAs. Net income p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________ FORM 10-Q ___________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 ______________ ...

During this call, we will also be referring to certain non-GAAP financial measures. These non-GAAP measures are not superior to or replacement for the comparable GAAP measures. But we believe these measures help investors gain a more complete understanding of results. A reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures is available in the earnings press release and earnings call presentation slides provided in connection with today's call. The slides are availa ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________ FORM 10-Q ___________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 _____________ ...

Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2023 Earnings Conference Call April 25, 2023 9:00 AM ET Conference Call Participants Good day, ladies and gentlemen, and welcome to the Medpace First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this call may be recorded. Good morning. And thank you for joining Medpace???s first quarter 2023 earnings confere ...

FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding our forecasted financial results and the effective tax rate used for non-GAAP adjustment purposes. In this context, forward-lookin ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ FORM 10-K ________________________________________________________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...

Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2022 Earnings Conference Call February 14, 2023 9:00 AM ET Operator I would now like to introduce your host for today's conference call, Lauren Morris, Medpace???s Director of Investor Relations. You may begin. Good morning. And thank you for joining Medpace's fourth quarter and full year 2022 earnings conference call. Also on the call today is our CEO, August Troendle; our President, Jesse Geiger; and our CFO, Kevin Brady. Before we begin, I would like to remind you ...

| --- | --- | |-------|-------| | | | | | | | | | This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding our forecasted financial results and the effective tax rate used for non-GAAP adjustment purposes. In this context, forward-looking state ...